期刊文献+

肾胺酶与肾交感神经活性在慢性心力衰竭中的作用 被引量:3

Roles of renalase and renal sympathetic nerve activity in patients with chronic heart failure
下载PDF
导出
摘要 摘要目的:探讨肾胺酶与局部肾交感活性在慢性心力衰竭中的作用。方法:测定60例慢性心力衰竭患者和42例对照组血浆肾素(PRA)、血管紧张素Ⅰ(AngⅠ)、血管紧张素Ⅱ(AngⅡ)、肾上腺素(E)、去甲肾上腺素(NE)及肾胺酶活性。观察不同纽约心功能分级(NYHA)心衰患者间PRA及肾胺酶等指标间的差异及相关关系。结果:心衰组PRA、E、NE、AngⅠ活性增高,肾胺酶活性降低。与轻微心衰组相比,严重心衰组肾胺酶活性及左室射血分数降低(P分别为〈0.01、0.034),N末端脑钠尿肽前体(NT—proBNP)及PRA增高(均P〈0.01)。线性相关分析显示肾胺酶活性与L0gNT-pmBNP(r=-0.400,P=0.002)。LogNE(r=-0.315,P=0.014)呈负相关。多因素LDgistic回归分析显示,NT-proBNP(OR=6.962,95%CI=1.223~39.638)、PRA(OR=3.736,95%CI=1.031-13.540)及肾胺酶活性(OR=0.253,95%CI=0.069—0.927)是影响NYHA级别高低的独立因素。结论:慢性心衰患者反映肾交感神经活性的指标PRA增加,肾胺酶活性降低,且与心衰严重程度有关。 Objective To assess the roles of renalase and renal sympathetic nerve activity in patients with chronic heart failure (CHF). Methods Plasma renin activity (PRA), angiotensin Ⅰ (Ang Ⅰ ), angiotensin Ⅱ (Ang Ⅱ ), adrenaline (E), noradrenaline (NE) and renalase were determined in 60 patients with C HF (CHF group) and in 42 healthy cases (control group). Data were compared between patients with mild and serious CHF. Results PRA, E, NE and Ang Ⅰ increased and renalase decreased in CHF group than those in control group. Compared with mild CHF, renalase and left ventricular ejection fraction decreased (P 〈 0.01, 0.034), while N- terminal pro-B-type natriuretic peptide (NT-proBNP) and PRA significantly increased (P 〈 0.01 ). Linear correlation analysis showed that renalase was inversely correlated with Log NT-proBNP (r = -0.400, P = 0.002) and Log NE (r = -0.314, P = 0.014). Logistic regression analysis showed that NT-proBNP (OR = 6.963, 95%CI = 1.223 to 39.638), PRA(OR = 3.736, 95%CI = 1.031 to 13.540) and renalase (OR = 0.253, 95%CI = 0.069 to 0.927) were associated with increased NYHA classes. Conclusions PRA would increase while renalase would decrease in patients with CHF. PRA and renalase were correlated to the severity of CHF.
出处 《实用医学杂志》 CAS 北大核心 2014年第20期3239-3242,共4页 The Journal of Practical Medicine
基金 广州市科技计划项目(编号:2013J4100028)
关键词 心力衰竭 肾胺酶 交感神经 Heart failure Renalase Sympathetic nerve
  • 相关文献

参考文献13

  • 1Sobotka PA, Krum H, Bohm M, et al. The role of renal denervation in the treatment of heart failure [J]. Curr Cardiol Rep, 2012,12(3) :285-292.
  • 2Li X, Huang R, Xie Z, et al. Renalase, a new secretory enzyme : Its role in hypertensive-ischemic cardiovascular diseases [J]. Med Sci Monit, 2014,20(2):688-692.
  • 3Gu R, Lu W, Xie J, et al. Renalase deficiency in heart failure model of rats-a potential mechanism underlying circulating norepinephrine accumulation [J]. PLoS One, 2011,31 (6): e14633.
  • 4McKee PA, Castelli WP, MeNamara PM, et al. The natural history of congestive heart failure: the Framingham study [J]. N Engl J Med, 1971,285(26) : 1141-1146.
  • 5Petersson M, Friberg P, Eisenhofer G, et al. Long-term outcome in relation to renal sympathetie activity in patients with chronie heart failure [ J ]. Eur Heart J, 2005,26 (9) : 906-913.
  • 6Xu J, Li G, Wang P, et al. Renalase is a novel, soluble monoamine oxidase that regulates cardiac function and blood pressure [ J ]. J Clin Invest, 2005,115 (5) : 1275 - 1280.
  • 7郑淑蓓,金领微,黄文,徐玉兰.肾胺酶与慢性肾脏病患者心血管事件关系的研究进展[J].中华肾脏病杂志,2012,28(6):502-505. 被引量:2
  • 8Desir, G. Novel insights into the physiology of renalase and its role in hypertension and heart diseases [J]. Pediatr Nephrol, 2012,27(5) :719-725.
  • 9Pettersson A, Hedner J, Hedner T. Renal interaction between sympathetic activity and ANP in rats with chronic ischaemic heart failure [J]. Acta Physiol Scand, 1989,135(4) :487-492.
  • 10Nozawa T, Igawa A, Fujii A, et al. Effects of long-term renal sympathetic denervation on heart failure after myocardial infarction in rats [J]. Heart Vessels, 2002,16(2) :51-56.

二级参考文献32

  • 1Xu J, Li G, Wang P, et al. Renalase is a novel, soluble monoamine oxidase that regulates cardiac function and bloodpressure. J Clin Invest, 2005, 115: 1275-1280.
  • 2Desir GV. Regulation of blood pressure and cardiovascular function by renalase. Kidney Int, 2009, 76: 366-370.
  • 3Hennebry SC, Eikelis N, Socratous F, et al. Renalase, a novel soluble FAD-dependent protein, is synthesized in the brain and peripheral nerves. Mol Psychiatry, 2010, 15: 234- 236.
  • 4Desir G. Novel insights into the physiology of renalase and its role in hypertension and heart disease. Pediatr Nephrol, 2012, 27: 719-725.
  • 5Wang J, Qi S, Cheng W, et aI. Identification, expression and tissue distribution of a renalase homologue from mouse. Mol Biol Rep, 2008, 35: 613-620.
  • 6Xu J, Desir GV. Renalase, a new renal hormone: its role in health and disease. Curr Opin Nephrol Hypertens, 2007, 16: 373-378.
  • 7Binda C, Mattevi A, Edmondson DE, et al. Structure- function relationships in flavoenzyme-dependent amine oxidations: a comparison of polyamine oxidase and monoamine oxidase. J Biol Chem, 2002, 277: 23973-23976.
  • 8Saura J, Richards JG, Mahy N, et al. Differential age- related changes of MAO-A and MAO-B in mouse brain and peripheral organs. Neurobiol Aging, 1994, 15: 399-408.
  • 9Saura J, Kettler R, Da Prada M, et al. Quantitative enzyme radioautography with 3H-Ro 41-1049 and 3H-Ro 19-6327 in vitro: localization and abundance of MAO-A and MAO-B in rats CNS, peripheral organs, and human brain. J Neurosci, 1992, 12: 1977-1999.
  • 10Li G, Xu J, Wang P, et al. Catecholamines regulate the activity, secretion, and synthesis of renalase. Circulation, 2008, 117: 1277-1282.

共引文献1

同被引文献27

  • 1Meng Gao,Xingxing Zhang,Xin Chen,el a1.Prenatal exposure to lipopolysaccharide results in local RAS activation in the adipose tissue of rat offspring[J].PLo S One,2014,9(10):e111376.
  • 2Catalina Sánchez-魣lvarez,Miguel González-Vélez,Erik Stilp,et a1.Renal Sympathetic Denervation in the Treatment of Resistant Hypertension[J].Yale J Biol Med,2014,87(4):527-535.
  • 3Jialu Hu,Meng Ji,Conway Niu,et al.Effects of renal sympathetic denervation on post-myocardial infarction cardiac remodeling in rats[J].PLo S One,2012,7(9):e45986.
  • 4Henry Krum,Markus Schlaich,Paul Sobotka.Renal sympathetic nerve ablation for treatment-resistant hypertension[J].Br J Clin Pharmacol,2013,76(4):495-503.
  • 5Silvio Antoniak,Nigel Mackman.Coagulation,Protease activated receptors and viral myocarditis[J].J Cardiovasc Transl Res,2014,7(2):203-211.
  • 6Jun Gui,Yan Yue,Ruizhen Chen,et al.A20(TNFAIP3)Alleviates CVB3-induced myocarditis via inhibiting NF-κB signaling[J].PLo S One,2012,7(9):e46515.
  • 7Shelley D,Miyamoto R,Brown D,et al.Cardiac-Cell-specific apoptotic and cytokine responses to reovirus infection:determinants of myocarditic phenotype[J].J Card Fail,2009,15(6):529-539.
  • 8Nikolaos G.Frangogiannis.Matricellular proteins in cardiac adaptation and disease[J].Physiol Rev,2012,92(2):635-688.
  • 9Torreilles F,et al.[J].Brain Res Rev,1999,30:153-163.
  • 10Longa Z,Weinstein PR,Carson Setal.Revesible middle cerebra artery:without craniotomy in rats[J].J Stroke,1989,20:84-91.

引证文献3

二级引证文献45

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部